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Presentations
Views: fundamental building blocks in the process of
knowledge discovery, Bannai H, Tamada Y, Maruyama
O, Miyano S, The 14th International FLAIRS Confer-
ence,  Florida,   21-23 May.
Selecting informative genes for cancer classification
using gene expression data, Akutsu, T, Miyano, S, IEEE-
EURASIP Workshop on Non-linear Signal and Image
Processing - NSIP-01, Baltimore, 1-3 June.
VML: a view modeling language for computational
knowledge discovery, Bannai H (U Tokyo), Tamada Y
(Tokai U), Maruyama O (Kyushu U), Miyano S, The
Fourth Internatinal Conference on Discovery Science,
Washington DC, 26-28 November.
Learning conformation rules, Maruyama O, Shoudai
T,  Furuichi E, Kuhara S, Miyano S, The Fourth
Internatinal Conference on Discovery Science, Washing-
ton DC, 26-28 November.
XML documentation of biopathways and their simula-
tions in Genomic Object Net, Matsuno H (Yamaguchi U),
Doi A (Yamaguchi U), Hirata Y, Miyano S, The Twelfth
Scope of Research
This laborabory develops research on computational knowledge discovery, e.g.  inference of pathway information
from gene expression profile data, and simulation system for cells and organisms through the biopathway simulation of
gene regulatory networks, signaling pathways, metabolic pathways, and physical simulations, etc.  With this approach,
the functions of genes and systems of genes will be analyzed and predicted.
International Conference on Genome Informatics, Tokyo,
17-19 December.
Genomic Object Net: Hybrid Object Net Architecture
and XML Visualization for Biopathway Simulation,
Third Biopathway Consortium Meeting, Copenhagen,
19-20 July.
HypothesisCreator: concepts for accelerating the com-
putational knowledge discovery process, Bannai H,
Tamada Y, Maruyama O, Miyano S, The 18th Machine
Intelligence Conference, York, England, 19-21 Septem-
ber.
Grants
Miyano S, Genome-Wide Analysis of Genes Related
to Disease Susceptibility and Drug Responsiveness, Re-
search for Future Programs by Japan Society for the Pro-
motion of Science, 1 April  2000 -  31 March 2004.
Miyano S, Mathematical Foundations of Computa-
tional Knowledge Discovery from cDNA Microarray
Data, Grant-in-Aid for Scientific Research (B)(1), 1 April
2000 -31 March 2003.
ICR Annual Report, Vol. 8, 2001 57
Genomic Object Net: Towards Biopathway
Modeling and Simulation
Like in high-energy physics, if events in biological or-
ganisms could be simulated and predictions could be
made on computers, such system would contribute to
drug discovery and therapy in a drastically efficient way,
and biology would be driven to a new era with a new
methodology for discovery.  This idea is not yet fully real-
ized but some portions are being realized.
Biological knowledge in molecular and cellular biol-
ogy has been typically represented as a series of natural
language narratives together with schemes/pictures
which would describe the processes of interactions and
effects of various entities, e.g. molecules, stimuli, loca-
tions, etc.  True understanding and interpretation of such
knowledge often lie only in the human minds, i.e. experi-
mental biologists.
We have been developing Genomic Object Net for
modeling and simulating biopathways.  Two key tech-
niques are employed; hybrid functional Petri net (HFPN)
for basic architecture, and XML for biopathway represen-
tation and simulation visualization. With Genomic Object
Net, users can model biopathways as HFPNs based on
their intuitive understanding and can result in confidence
that the models designed with this software coincides
with the understanding and knowledge in their minds.
Our target pathways are structurally complex dynamic
causal interactions and processes of various biological
objects such as genomic DNA, mRNA, proteins, func-
tional proteins, molecular transactions occurring at spe-
cific locations and time.  For example, metabolic path-
ways, gene regulatory networks, and signal transduction
cascades are counted as typical biopathways.  With Ge-
nomic Object Net, we can observe in silico how these ob-
jects interact and behave quantitatively and qualitatively
in biopathways.Genomic Object Net enables investiga-
tions which are usually impossible in experimental sys-
tems, such as searching for multiple small perturbations
that produce large effects when they are combined.
Differencies between observed system behavior by simu-
lation and observations in laboratory may suggest a
change of model and will invoke new experiments for dis-
covery.  The large-scale modeling, such as the whole
yeast biopathway modeling, is also feasible with the
forthcoming version of this software if we combine vari-
ous information from many difference sources, e.g.
cDNA microarray data, protein interaction data, etc.  The
modeling process should go along with experimental ac-
tivity in laboratory and Genomic Object Net will do so.
The approach with such predictive simulations has obvi-
ously a big possibility to create a tremendous value in
drug discovery and therapeutic development.
1. http://www.GenomicObject.Net/
Genomic Object Net Snapshot
